Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Duloxetine HCL DR Capsule
Medication labelWhy this: Advisory · dailymed-prescription
1 INDICATIONS AND USAGE Duloxetine delayed-release capsules are indicated for the treatment of: Major depressive disorder in adults Generalized anxiety disorder in adults and pediatric patients 7 years of age and older Diabetic peripheral neuropathic pain in adults Fibromyalgia in adults Chronic musculoskeletal pain in adults Additional pediatric use information is approved for Eli Lilly and Company, Inc.’s CYMBALTA (duloxetine) delayed-release capsules. However, due to Eli Lilly and Company Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
- generic_name
- duloxetine hcl
- product_names
- Duloxetine HCL
- ndc
- 80425-0146, 27241-098, 80425-0146-2, 80425-0146-1, 80425-0146-3
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en